https://www.claytonbiotech.com/clfr-patent/immunodominant-peptides/2026-05-03T14:29:33+00:00https://www.claytonbiotech.com/clfr-patent/immunodominant-peptides-2/2026-05-03T14:29:49+00:00https://www.claytonbiotech.com/clfr-patent/proteins-for-ehrlichia-diagnosis-and-vaccination/2026-05-03T14:30:03+00:00https://www.claytonbiotech.com/clfr-patent/vaccines-for-the-ehrlichioses-comprising-gp19-or-vlpt-antigens/2026-05-03T14:30:19+00:00https://www.claytonbiotech.com/clfr-patent/immunoreactive-ehrlichia-p120-p140-epitopes-and-uses-thereof/2026-05-03T14:30:36+00:00https://www.claytonbiotech.com/clfr-patent/chimeric-immunogenic-polypeptides/2026-05-03T14:30:54+00:00https://www.claytonbiotech.com/clfr-patent/p153-and-p156-antigens-of-ehrlichia-bacteria/2026-05-02T09:09:55+00:00https://www.claytonbiotech.com/clfr-patent/vaccines-comprising-immunoreactive-glycoprotein-gp19-of-ehrlichia-canis/2026-05-02T09:10:46+00:00https://www.claytonbiotech.com/clfr-patent/ehrlichia-immunoreactive-gp47-and-gp36-antigens-for-diagnosis-and-vaccination/2026-05-03T14:31:14+00:00https://www.claytonbiotech.com/clfr-patent/immunoreactive-ferric-binding-protein-of-ehrlichia/2026-05-03T14:31:29+00:00https://www.claytonbiotech.com/clfr-patent/biologic-drug-for-the-treatment-of-cancer-and-disease/2026-05-02T09:23:51+00:00https://www.claytonbiotech.com/clfr-patent/therapeutic-agents-comprising-pro-apoptotic-proteins/2026-05-02T09:24:15+00:00https://www.claytonbiotech.com/clfr-patent/granzyme-molecules-and-therapies/2026-05-02T09:24:35+00:00https://www.claytonbiotech.com/clfr-patent/rspo1-targeting-therapies/2026-05-02T09:24:55+00:00https://www.claytonbiotech.com/clfr-patent/leader-peptides-for-secreting-recombinant-proteins/2026-05-02T09:22:11+00:00https://www.claytonbiotech.com/clfr-patent/methods-of-microbiome-characterization-and-monitoring/2026-05-03T14:20:13+00:00https://www.claytonbiotech.com/clfr-patent/methods-for-predicting-kinase-inhibitor-resistance/2026-05-03T14:22:22+00:00https://www.claytonbiotech.com/clfr-patent/steap2-inhibitors-for-the-treatment-of-liver-cancers/2026-05-02T09:28:26+00:00https://www.claytonbiotech.com/clfr-patent/recombinant-filaggrin-polypeptides-for-cell-importation/2026-05-02T09:53:38+00:00https://www.claytonbiotech.com/clfr-patent/neural-network-systems-for-smorf-peptides/2026-05-03T14:20:42+00:00https://www.claytonbiotech.com/clfr-patent/systems-and-methods-for-ultrasound-and-photoacoustic-guidance-of-coronary-procedures/2026-05-03T14:21:28+00:00https://www.claytonbiotech.com/clfr-patent/automated-coronary-plaque-characterization-and-risk-assessment-using-virtual-histology-ivoct/2026-05-03T14:00:22+00:00https://www.claytonbiotech.com/clfr-patent/systems-and-methods-for-endometrial-tissues-identification/2026-05-02T10:05:18+00:00https://www.claytonbiotech.com/clfr-patent/systems-and-methods-for-coronary-occlusion-treatment/2026-05-03T14:00:42+00:00https://www.claytonbiotech.com/clfr-patent/multi-channel-orthogonal-confolutional-neural-networks/2026-05-03T14:28:32+00:00https://www.claytonbiotech.com/clfr-patent/immunoreactive-polypeptides/2026-05-03T14:31:46+00:00https://www.claytonbiotech.com/clfr-patent/combination-therapy-for-the-treatment-of-metabolic-diseases-and-disorders/2026-05-03T13:58:17+00:00https://www.claytonbiotech.com/clfr-patent/class-iia-hdac-inhibitors-for-the-treatment-of-infection/2026-05-02T09:56:32+00:00https://www.claytonbiotech.com/clfr-patent/apparatus-and-methods-for-intra-vascular-laser-lithotripsy/2026-05-03T14:20:27+00:00https://www.claytonbiotech.com/clfr-patent/systems-and-methods-for-laser-induced-calcium-fractures/2026-05-03T14:21:46+00:00https://www.claytonbiotech.com/clfr-patent/methods-and-apparatus-for-high-speed-and-high-aspect-ratio-laser-subtractive-material-processing/2026-05-02T10:06:36+00:00https://www.claytonbiotech.com/clfr-patent/apparatus-and-methods-for-phase-agnostic-stimuli/2026-05-02T10:06:09+00:00https://www.claytonbiotech.com/clfr-patent/apparatus-and-method-for-evaluations-bright-spot-indications-observed-through-optical-oct/2026-05-03T13:55:18+00:00https://www.claytonbiotech.com/clfr-patent/oct-image-guided-laser-knife/2026-05-03T13:56:55+00:00https://www.claytonbiotech.com/clfr-patent/methods-and-probiotic-compositions-for-the-treatment-of-metabolic-diseases-and-disorders/2026-05-03T14:18:24+00:00https://www.claytonbiotech.com/clfr-patent/methods-for-treating-insulin-resistance-and-for-sensitzing-patients-to-gip1-agonist-therapy/2026-05-03T14:02:20+00:00https://www.claytonbiotech.com/clfr-patent/methods-and-probiotic-compositions-for-the-treatment-of-bone-disorders/2026-05-03T14:18:59+00:00https://www.claytonbiotech.com/clfr-patent/shp2-inhibitors-and-methods-of-use-thereof/2026-05-03T14:04:36+00:00https://www.claytonbiotech.com/clfr-patent/homeobox-factor-stimulating-insulin-expression/2026-05-03T14:05:42+00:00https://www.claytonbiotech.com/clfr-patent/treatment-of-diabetes-by-co-stimulation-of-crf-r1-and-crf-r2/2026-05-03T14:06:54+00:00https://www.claytonbiotech.com/clfr-patent/soluble-g-protein-coupled-receptors/2026-05-03T14:08:11+00:00https://www.claytonbiotech.com/clfr-patent/corticotropin-releasing-factor-receptor-2-inhibitors-and-uses-thereof/2026-05-03T14:09:34+00:00https://www.claytonbiotech.com/clfr-patent/methods-for-making-and-using-differentiated-neural-cells/2026-05-03T14:21:00+00:00https://www.claytonbiotech.com/clfr-patent/elimination-of-proliferating-cells-from-stem-cell-derived-grafts/2026-05-03T14:18:43+00:00https://www.claytonbiotech.com/clfr-patent/elimination-of-proliferating-cells-from-stem-cell-derived-grafts-2/2026-05-03T14:19:19+00:00https://www.claytonbiotech.com/clfr-patent/generation-of-dopaminergic-neurons/2026-05-03T14:19:33+00:00https://www.claytonbiotech.com/clfr-patent/transgenic-mice-deficient-in-corticotropin-releasing-factor-receptor-2-crfr-2/2026-05-03T14:26:49+00:00https://www.claytonbiotech.com/clfr-patent/stem-cell-clones-with-defined-differentiation-capabilities/2026-05-03T14:28:17+00:00https://www.claytonbiotech.com/clfr-patent/methods-for-generating-engineered-enzymes/2026-05-03T14:24:07+00:00https://www.claytonbiotech.com/clfr-patent/3d-structure-of-an-extracellcular-domain-of-a-b1-g-protein/2026-05-03T14:25:25+00:00https://www.claytonbiotech.com/clfr-patent/a-conditional-gene-knock-down-system-using-rnai/2026-05-03T14:26:29+00:00https://www.claytonbiotech.com/clfr-patent/methods-of-engineering-proteases-and-other-enzymes-using-yeast/2026-05-03T14:28:00+00:00